ANN SERVIES: Open Payments
NPI 1821177759 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,592 in 15 payments from 13 companies in 2025. Trend: 2023 $2,885 · 2024 $1,676 · 2025 $1,592
Food & beverage: $1,592
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $254 |
| JAZZ PHARMACEUTICALS INC. | 1 | $147 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| ARGENX US, INC. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Exelixis Inc. | 1 | $122 |
| Amgen Inc. | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| Aimmune Therapeutics, Inc. | 1 | $110 |
Products named: RYBREVANT, ZIIHERA, DUPIXENT, VYVGART, JARDIANCE, Auvelity, CABOMETYX, TAVNEOS.
Industry payments across AZ — which companies pay providers there.
